Author(s): Kisselev AF, Goldberg AL
Abstract Share this page
Abstract The 26S proteasome is a 2.4 MDa multifunctional ATP-dependent proteolytic complex, which degrades the majority of cellular polypeptides by an unusual enzyme mechanism. Several groups of proteasome inhibitors have been developed and are now widely used as research tools to study the role of the ubiquitin-proteasome pathway in various cellular processes, and two inhibitors are now in clinical trials for treatment of multiple cancers and stroke.
This article was published in Chem Biol
and referenced in Journal of Glycomics & Lipidomics